Early Conversion to Belatacept-based Therapy Improves Graft Function in Renal Transplant Patients

被引：0
|
作者：
Huang, N. [1 ]
Yang, C. J. [2 ]
Movileanu, I. [1 ]
Dvorai, R. H. [3 ]
Ecal, K. M. [1 ]
Saidi, R. F. [1 ]
Senay, A. N. Ayla [1 ]
Gallay, B. [4 ]
Hanlon, M. J. [1 ]
Narsipur, S. [4 ]
Laftavi, M. R. [1 ]
Shahbazov, R. [1 ]
机构：
[1] SUNY Upstate Med Univ, Surg, Syracuse, NY 13210 USA
[2] SUNY Upstate Med Univ, Pharm, Syracuse, NY 13210 USA
[3] SUNY Upstate Med Univ, Pathol, Syracuse, NY 13210 USA
[4] SUNY Upstate Med Univ, Med, Syracuse, NY 13210 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
935
引用
收藏
页码：692 / 692
页数：1
相关论文
共 50 条
  • [21] Evaluation of a Belatacept-Based Immunosuppression Regimen in Kidney Transplant Recipients
    Brisku, R.
    Rudzik, K.
    Augustine, J.
    Eckardt, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S848 - S849
  • [22] Conversion from Calcineurin Inhibitor? to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial
    Budde, Klemens
    Prashar, Rohini
    Haller, Hermann
    Rial, Maria C.
    Kamar, Nassim
    Agarwal, Avinash
    de Fijter, Johan W.
    Rostaing, Lionel
    Berger, Stefan P.
    Djamali, Arjang
    Leca, Nicolae
    Allamassey, Lisa
    Gao, Sheng
    Polinsky, Martin
    Vincenti, Flavio
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (12): : 3252 - 3264
  • [23] CONVERSION FROM CALCINEURIN INHIBITOR-TO BELATACEPT-BASED MAINTENANCE IMMUNOSUPPRESSION IN HEART TRANSPLANT PATIENTS: A SINGLE-CENTER EXPERIENCE
    Fontenay, S.
    Tesmoingt, C.
    Arnaud, P.
    Verdonck, C.
    Dorent, R.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 16 - 16
  • [24] Belatacept Conversion in Elderly Renal Transplant Recipients
    Durst, M.
    Felix, D.
    Jorgenson, M.
    Descourouez, J.
    Astor, B. C.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 691 - 691
  • [25] Conversion to Belatacept in HIV(+) Renal Transplant Recipients
    Santeusanio, A.
    Bhansali, A.
    Shapiro, R.
    De Boccardo, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 436 - 436
  • [26] Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant
    Manook, Miriam
    Olaso, Danae
    Anwar, Imran J.
    Yoon, Janghoon
    Delaura, Isabel
    Bae, Yeeun
    Moris, Dimitrios
    Shaw, Brian
    Song, Mingqing
    Farris, Alton B.
    Jackson, Annette
    Kwun, Jean
    Knechtle, Stuart
    SCIENCE ADVANCES, 2023, 9 (20)
  • [27] Quadruple Therapy Tacrolimus-Sparing Belatacept-based Maintenance Immunosuppression after an Arm Transplant
    Landin, Luis
    Jimenez, Carlos
    TRANSPLANTATION, 2018, 102 : S435 - S435
  • [28] Early Sirolimus Conversion as Rescue Therapy in Kidneys With Prolonged Delayed Graft Function in Deceased Donor Renal Transplant
    Tahir, W.
    Hakeem, A.
    Dawrant, M.
    Prasad, P.
    Lee, M.
    Menon, K.
    Attia, M.
    Baker, R.
    Ahmad, N.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (06) : 1610 - 1615
  • [29] Cost Effectiveness of a Belatacept-Based Regimen in Kidney Transplant Recipients.
    Caccioppoli, V.
    MacLasco, A.
    Chan, K.
    Gandhi, R.
    LaBella, S.
    Somers, L.
    Rogers, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 183 - 183
  • [30] Conversion to Belatacept as Rescue Therapy in Kidney Transplant Recipients with Severe Graft Dysfunction.
    Oldhafer, F.
    Hiss, M.
    Schwarz, A.
    Haller, H.
    Einecke, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 744 - 744
12345